NEWSROOM
News & Stories
Newsroom
Press Releases
MammaPrint breast cancer test ID’s women who can avoid chemotherapy
KARE, Minneapolis-St.Paul-2013 This TV report tells how you can “know your breast cancer” better through this genomic, personalized medicine test, which is part of the Symphony suite of breast cancer tests.
Study Shows Half of Early-Stage Breast Cancer Patients May Safely Avoid Chemotherapy
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, February 4, 2013 – The MammaPrint breast cancer test can dramatically reduce the number of women who need to undergo chemotherapy to treat the disease, according to a newly Read More







